A senior official from the European Medicine Agency said in an interview that the benefits of the shot from the AstraZeneca vaccine still have possible risks. They said that there is a clear link between the vaccine and rare blood clots in the brain.
While WHO and other regulators have held this vaccine, many European countries have restricted its use. Experts are still not certain what causes the response.
Researchers from Germany and Norway said last month that the vaccine could trigger an immune response. The formation of blood clots in the brain is one of the immune responses.
AstraZeneca did not quickly respond to this matter. But said that it has found no link between its vaccine and higher risk of blood clots.
Apply Now. Hodler Capital Group will help you access business financing. We will show you how to build your business credit. We can also help you build a business website. To start growing your business contact us now.